Skip to content

Your Bag (0)

Order within [time] for dispatch today

Your cart is currently empty.

Browse our research-backed peptides and optimised stacks to get started.

Pre-filled precision delivery systems

Coridion products are designed for consistent, research-grade delivery — so you can focus on results, not preparation.

Shop All Products
The Landmark Discovery of Reversal of Frailty and Organ Decline with FOXO4-DRI
Jun 30, 20261 min read

The Landmark Discovery of Reversal of Frailty and Organ Decline with FOXO4-DRI

  • Journal Context: Cell | Identifiers: DOI: 10.1016/j.cell.2017.02.031 / PMID: 28340339

  • Principal Investigators: Baar, M. P., Brandt, R. M., de Keizer, P. L., et al. (Erasmus University Medical Center, Netherlands)

  • Methodology: Longitudinal evaluation of fast-aging (progeroid) and naturally aged murine models administered systemic injections of FOXO4-DRI ($5\text{ mg/kg}$). Researchers tracked tissue changes, behavioral metrics (running speed, grip strength), hair density, and blood markers of kidney filtration.

  • Key Findings: FOXO4-DRI treatment induced targeted apoptosis exclusively in senescent cell lines. This selective clearance resulted in profound physiological rejuvenation:

    • Physical Fitness Restoration: Aged models demonstrated a massive recovery in physical endurance, significantly increasing voluntary wheel-running distance and maximum grip strength.

    • Structural Renovation: Fast-aging models experienced a complete restoration of fur density, reversing age-driven alopecia.

    • Organ Function Salvage: In both accelerated and natural aging lines, the peptide cleared senescent renal tubular cells, dropping plasma urea levels and reversing chronic renal filtration decline.

View study
Share